Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.15% | 16.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.15% | 16.64% | |||
| Cost of Revenue | 3.99% | 11.25% | |||
| Gross Profit | 11.58% | 21.51% | |||
| SG&A Expenses | -2.09% | 15.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.95% | 14.61% | |||
| Operating Income | 4.29% | -13.17% | |||
| Income Before Tax | -13.96% | -13.22% | |||
| Income Tax Expenses | -73.96% | 448.57% | |||
| Earnings from Continuing Operations | -13.52% | -13.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.52% | -13.67% | |||
| EBIT | 4.29% | -13.17% | |||
| EBITDA | 5.47% | -12.92% | |||
| EPS Basic | -13.20% | -8.70% | |||
| Normalized Basic EPS | 2.64% | -8.27% | |||
| EPS Diluted | -13.20% | -8.70% | |||
| Normalized Diluted EPS | 2.64% | -8.27% | |||
| Average Basic Shares Outstanding | 0.29% | 4.56% | |||
| Average Diluted Shares Outstanding | 0.29% | 4.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||